UnitedHealth Group has called in its CEO to deal with a Medicare Advantage program that’s crunching margins.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Oil giants Chevron and BP made moves to refine their business, drilling down on core segments that crude demand assures will be worth it.
Amazon’s patent to help doctors take better notes highlights the company’s massive bet on the healthcare space.
Elon Musk’s Boring Company has held talks with the Federal Railroad Administration about building a multi-billion dollar Amtrak tunnel.
Fossil fuel producers and OPEC have rained on the IEA’s parade, offering wildly different projections for future energy demand.
The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
Starbucks is buying two farms in Central America to conduct research on the crop at the heart of its business: coffee.
The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Toyota is investing $500 million into Joby Aviation, a California-based startup that wants to make flying taxis.
PepsiCo announced on Tuesday that it has agreed to buy Siete Foods for $1.2 billion, another food M&A deal this year.
Boeing is considering an emergency move: selling $10 billion in new stock to score some quick cash amid a union strike.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
Coca-Cola was one of several companies whose earnings last week flashed positive signs, despite the hail of uncertainty around tariffs.
Future battlefields will be shaped by AI weapons that defense firms and Big Tech are vying to build for the military. Guardrails are lagging.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.